We're moving to rndsystems.com. Come with us!
After August 17, 2026, Novus Biologicals products and services will no longer be available on this website; you will access all products and services on rndsystems.com. Create your R&D Systems online account today.
![Flow Cytometry: Polarity Sensitive Indicator of Viability Apoptosis Kit [IANBD] [NBP2-29611] - pSIVA-IANBD(TM) + PI shows progressive population staining as cells move from healthy towards death.](http://images.novusbio.com/fullsize/Polarity-Sensitive-Indicator-of-Viability-Apoptosis-Kit-[IANBD]-Flow-Cytometry-NBP2-29611-img0002.jpg "Flow Cytometry: Polarity Sensitive Indicator of Viability Apoptosis Kit [IANBD] [NBP2-29611] - pSIVA-IANBD(TM) + PI shows progressive population staining as cells move from healthy towards death.")
![Flow Cytometry: Polarity Sensitive Indicator of Viability Apoptosis Kit [IANBD] [NBP2-29611] - pSIVA-IANBD(TM) shows progressive population staining as cells move from healthy towards death.](http://images.novusbio.com/fullsize/Polarity-Sensitive-Indicator-of-Viability-Apoptosis-Kit-[IANBD]-Flow-Cytometry-NBP2-29611-img0001.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Double labeling of a normal blood sample treated with NBP2-31377, and immunostained for Lactoferrin (PE) and Lysozyme (FITC).](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0009.jpg "Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Double labeling of a normal blood sample treated with NBP2-31377, and immunostained for Lactoferrin (PE) and Lysozyme (FITC).")
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Flow cytrometric analysis of normal bone marrow (BM) after fixation and pemeabilization using NBP2-31377, followed by immunostaining for lactoferrin and MPO-C2.](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0001.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Flow cytrometric analysis of bone marrow (BM) from a leukemia patient after fixation and pemeabilization using NBP2-31377, followed by immunostaining for lactoferrin and MPO-C2](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0002.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Immunostaining with CD22-PE conjugate of undifferentiated leukemia cells of B-ALL type.](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0003.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Immunostaining with Nordic-MUbio CD3-PE conjugate of surface CD3-negative undifferentiated leukemia cells of T-ALL type.](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0004.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Immunostaining with Nordic-MUbio anti MPO-FITC conjugate of undifferentiated leukemia cells of AML type.](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0005.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Forward and side scatter pattern of a normal blood sample treated with NBP2-31377.](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0006.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Double labeling of a normal blood sample treated with NBP2-31377, and immunostained for Lactoferrin (PE) and MPO-C2 (FITC).](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0007.jpg)
![Flow Cytometry: Fixation and Permeabilization Flow Cytometry Kit [NBP2-31377] - Double labeling of a normal blood sample treated with NBP2-31377, and immunostained for CD3 (PE) and MPO-C2 (FITC).](http://images.novusbio.com/fullsize/Fixation-and-Permeabilization-Flow-Cytometry-Kit-Flow-Cytometry-NBP2-31377-img0008.jpg)
![Flow Cytometry: EV-FACS (Serum) Flow Cytometry Kit [NBP3-18362] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C overnight.](http://images.novusbio.com/fullsize/nbp3-18362_ev-facs-serum-flow-cytometry-kit-flow-cytometry-1262024162851..jpg "Flow Cytometry: EV-FACS (Serum) Flow Cytometry Kit [NBP3-18362] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C overnight.")
![Flow Cytometry: EV-FACS (Urine) Flow Cytometry Kit [NBP3-18361] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C overnight.](http://images.novusbio.com/fullsize/nbp3-18361_ev-facs-urine-flow-cytometry-kit-flow-cytometry-1262024162753..jpg "Flow Cytometry: EV-FACS (Urine) Flow Cytometry Kit [NBP3-18361] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C overnight.")
![Flow Cytometry: EV-FACS (Cell Culture Media) Flow Cytometry Kit [NBP3-18363] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C overnight.](http://images.novusbio.com/fullsize/nbp3-18363_ev-facs-cell-culture-media-flow-cytometry-kit-flow-cytometry-126202416300..jpg "Flow Cytometry: EV-FACS (Cell Culture Media) Flow Cytometry Kit [NBP3-18363] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C overnight.")
![Flow Cytometry: EV-FACS (Plasma) Flow Cytometry Kit [NBP3-18360] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C over night.](http://images.novusbio.com/fullsize/nbp3-18360_ev-facs-plasma-flow-cytometry-kit-flow-cytometry-1262024162635..jpg "Flow Cytometry: EV-FACS (Plasma) Flow Cytometry Kit [NBP3-18360] - FACS profiling of exosomal markers CD9, CD63 and TM9SF4 in purified exosomes from Melanoma (MM1), Neuroblastoma (SH) and Glioblastoma (U87) cell supernatants. Exosome binding on FACS-beads was performed by incubation at 4C over night.")